Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and US perspectives
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 140 (1) , 83-89
Abstract
No abstract availableKeywords
Funding Information
- SNUH (2008-4533)
This publication has 23 references indexed in Scilit:
- Surgical Principles for Managing Stage IB2, IIA2, and IIB Uterine Cervical Cancer (Bulky Tumors) in JapanInternational Journal of Gynecological Cancer, 2014
- Cost-utility analysis of treatments for stage IB cervical cancerJournal of Gynecologic Oncology, 2014
- Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group studyBritish Journal of Cancer, 2013
- Prognostic significance of adenocarcinoma histology in women with cervical cancerGynecologic Oncology, 2012
- Value of PET-CT in Avoiding Multimodality Therapy in Operable Cervical CancerInternational Journal of Gynecological Cancer, 2010
- Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: A cost effectiveness analysisGynecologic Oncology, 2007
- Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005)International Journal of Gynecological Cancer, 2007
- Management strategies for stage IB2 cervical cancer: A cost-effectiveness analysisGynecologic Oncology, 2005
- Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the CervixJournal of Clinical Oncology, 2000
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997